Genexine, Inc. (KOSDAQ:095700)

Genexine Revenue

Genexine had revenue of 2.07B KRW in the quarter ending March 31, 2024, with 199.63% growth. This brings the company's total for the last twelve months to 5.81B, down -3.50% year-over-year. In the year 2023, Genexine had annual revenue of 4.43B, down -72.57%. That makes Genexine the 40,430th largest company in the world by revenue and 2,499th in South Korea.

• Revenue (ttm): 5.81B
• Revenue Growth: -3.50%
• P/S Ratio: 16.91
• Revenue / Employee: 67.53M
• Employees: 86
• Market Cap: 97.33B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Americas 2.68B 60.5%
• South Korea 1.72B 39.0%
• Asia 25.01M 0.6%

Fiscal year ended Dec 31, 2023 See the full Genexine breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.43B	-11.71B	-72.57%
Dec 31, 2022	16.14B	-20.69B	-56.18%
Dec 31, 2021	36.83B	18.28B	98.61%
Dec 31, 2020	18.54B	7.24B	64.06%
Dec 31, 2019	11.30B	5.05B	80.80%

Data Source: S&P Global Market Intelligence Last updated: May 14, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error